References
- Ahmadi A, Shirazi H, Pourbagher N, Akbarzadeh A, Omidfar K. 2014. An electrochemical immunosensor for digoxin using core-shell gold coated magnetic nanoparticles as labels. Mol Biol Rep. Epub Ahead of Print.
- Akbarzadeh A, Mikaeili H, Asgari D, Zarghami N, Mohammad R, Davaran S. 2012a. Preparation and in-vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers. Int J Nanomedicine. 7:511–526.
- Akbarzadeh A, Mohamad S, Davaran S. 2012d. Magnetic nanoparticles: preparation, physical properties and applications in biomedicine. Nanoscale Res Lett. 7:144–157.
- Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. 2013. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 8:102.
- Akbarzadeh A, Samiei M, Joo SW, Anzaby M, Hanifehpour Y, Nasrabadi HT, Davaran S. 2012c. Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line. J Nanobiotechnol. 10:46–58.
- Akbarzadeh A, Zarghami N, Mikaeili H, Asgari D, Goganian AM, Khiabani HK, Davaran S. 2012b. Synthesis, characterization and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Int J Nanotechnol Sci Environ. 5:13–25.
- Angelini G, Boncompagni S, De Maria P, De Nardi M, Fontana A, Gasbarri C, Menna E. 2007. Layer-by-layer deposition of shortened nanotubes or polyethylene glycol- derivatized nanotubes on liposomes:A tool for increasing liposome stability. Carbon. 45:2479–2485.
- Barenholz Y. 2001. Liposome application: problems and prospects. Curr Opin Colloid Interface Sci. 6:66–77.
- Batist G, Ramakrishnan G, Rao CS, Chandrasekharan A, Gutheil J, Guthrie T, et al. 2001. Reducedcardiotoxicity and preserved antitumor efficacy ofliposome-encapsulated doxorubicin and cyclophosphamidecompared with conventional doxorubicinand cyclophosphamide in a randomized, multicentertrial of metastatic breast cancer. J Clin Oncol. 19:1444–1454.
- Davaran S, Akbarzadeh A, Nejati-Koshki K, Alimohammadi S, Ghamari MF, Soghrati MM, et al. 2013. In vitro studies of NIPAAM-MAA-VP copolymer-coated magnetic nanoparticles for controlled anticancer drug release. JEAS. 3:108–115.
- Davaran S, Alimirzalu S, Nejati-Koshki K, Nasrabadi HT, Akbarzadeh A, Khandaghi AA, et al. 2014a. Physicochemical characteristics of Fe3O4 magnetic nanocomposites based on poly(Nisopropylacrylamide) for anti-cancer drugs delivery. Asian Pac J Cancer Prev. 15:49–54.
- Davaran S, Rezaei A, Alimohammadi S, Khandaghi AA, Nejati-Koshki K, Nasrabadi HT, Akbarzadeh A. 2014b. Synthesis and physicochemical characterization of biodegradable star-shaped poly lactide-co-glycolide– β -cyclodextrin copolymer nanoparticles containing albumin. Adv Nanoparticles. 3:14–22.
- Ebrahimnezhad Z, Zarghami N, Keyhani M, Amirsaadat S, Akbarzadeh S, Rahmati M, et al. 2013. Inhibition of hTERT gene expression by silibinin-loaded PLGA-PEG-Fe3O4 in T47D breast cancer cell line. BioImpacts. 3:67–74.
- Erkoc F, Erkoc S. 2002. Theoretical investigation of flavonoids naringenin and genistein. Theochem. 583:163–167.
- Ghasemali S, Nejati-Koshki K, Akbarzadeh A, Tafsiri E, Zarghami N, Rahmati-Yamchi M, et al. 2013. Study of inhibitory effect of β-cyclodextrin-helenalin complex on HTERT gene expression in T47D breast cancer cell line by real time quantitative PCR (q-PCR). Asian Pac J Cancer Prev. 14:6949–6953.
- He X, Liu RH. 2008. Phytochemicals of apple peels: isolation, structure elucidation, and their antiproliferative and antioxidant activities. J Agric Food Chem. 56:9905–9910.
- Klein E, Matis M, Lukes V, Cibulkova Z. 2006. The applicability of AM1and PM3semi-empirical methods for the study of N-H bond dissociation enthalpies and ionization potential of amine type antioxidants. Polym Degrad Stab. 91:262–270.
- Kouhi M, Vahedi A, Akbarzadeh A, Hanifehpour Y, Joo SW. 2014. Investigation of quadratic electro-optic effects and electro absorption process in GaN/AlGaN spherical quantum dot. Nanoscale Res Lett. 9:131–136.
- Kaul G, Amiji M. 2002. Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery. Pharm Res. 19:1061–1067.
- Lee SE, Hwang HJ, Ha JS, Jeong HS, Kim JH. 2003. Screening of medicinal plant extracts for antioxidant activity. Life Science73:167–117.
- Lefer DJ, Granger DN. 2000. Oxidative stress and cardiac disease. Am J Med. 109:315–323.
- Lian T, Ho RJ. 2001. Trends and developments in liposome drug delivery systems. J Pharm Sci. 90:667–680.
- Nejati-Koshki K, Akbarzadeh A, Pourhasan-Moghadam M, Joo SW. 2013. Inhibition of leptin and leptin receptor gene expression by silibinin- curcumin combination. Asian Pac J Cancer Prev. 14: 6595–6599.
- Nelson SK, Bose SK, Grunwald GK, Myhill P, Mc Cord JM. 2006. The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. Free Radic Biol Med. 40:341–347.
- Phromnoi K, Yodkeeree S, Anuchapreeda S, Limtraku P. 2009. Inhibition of MMP-3 activity and invasion of the MDAMB-231 human invasive breast carcinoma cell line by bioflavonoids. Acta Pharmacol Sin. 30:1169–1176.
- Pourhassan-Moghaddam M, Rahmati-Yamchi M, Akbarzadeh A, Daraee H, Nejati-Koshki K, Hanifehpour Y, Joo SW. 2013. Protein detection through different platforms of immuno-loop-mediated isothermal amplification. Nanoscale Res Lett. 8:485.
- Rezaei-Sadabady R, Zarghami N, Barzegar A, Eidi A, Akbarzadeh A, Rezaei-Tavirani M. 2013. Studies of the relationship between structure and antioxidant activity in interesting systems, including tyrosol, hydroxytyrosol derivatives indicated by quantum chemical calculations. Soft. 2:13–18.
- Sahoo SK, Labhasetwar V. 2003. Nanotech approaches to drug delivery and imaging. Drug Discov Today. 15:1112–1120.
- Sharma A, Sharma US. 1997. Liposomes in drug delivery: progress and limitations. Int J Pharm. 154:123–140.
- Stone WL, Mukherjee S, Smith M, Das SK. 2002. Therapeutic uses of antioxidant liposomes. Methods Mol Biol. 199:145–161.
- Stone WL, Smith M. 2004. Therapeutic uses of antioxidant liposomes. Mol Biotechnol. 27:217–230
- Tabatabaei Mirakabad FS, Akbarzadeh A, Zarghami N, Zeighamian V, Rahimzadeh A, Alimohammadi S. 2014. PLGA-cased nanoparticles as cancer drug delivery systems. Asian Pac J Cancer Prev. 15: 517–535.
- Torchilin VP. 2005. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 4:145–160.
- Valizadeh A, Mikaeili H, Samiei M, Farkhani SM, Zarghami N, Kouhi M, et al. 2012. Quantum dots: synthesis, bioapplications, and toxicity. Nanoscale Res Lett. 7:276.
- Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK. 1995. Vascular permeabilityin a human tumor xenograft: molecular sizedependence and cutoff size. Cancer Res. 55:3752–3756.
- Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. 2008. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 83:761–769.